SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Published on by Top Pharmaceutical

SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Prof. Dr. SILVIA MARIA DÍAZ PRADO, University of A Coruña, Spain

Prof. Dr. Silvia María Díaz Prado is a Professor of Anatomy at the University of A Coruña and leads the Cellular Therapy and Regenerative Medicine Group at INIBIC. With a PhD in Biology (2004), her research spans tissue engineering, stem cells 🧬 (including iPSCs), novel biomaterials, 3D bioprinting 🖨️, and nanoparticle drug delivery 💊. She has published 68 articles (H-index: 24), 32 book chapters, and presented at 215 conferences. Dr. Díaz Prado has led 33 research projects, supervised over 50 theses, and received 7 research awards 🏅. She coordinates the Master’s in Health Care and Research program.

Publication Profile

Google Scholar

Education

Prof. Dr. Silvia María Díaz Prado 🎓 holds a Ph.D. in Biology (2004) from the University of A Coruña, where she serves as a Professor of Anatomy 🧠 and coordinates the Master’s Degree in Health Care and Research 💉📚. With a distinguished academic career, she has played a pivotal role in shaping advanced medical education and fostering scientific inquiry 🔬. Her dedication to teaching and mentorship has inspired countless students and researchers, reinforcing her status as a respected leader in the biomedical field 🌟. Prof. Dr. Díaz Prado continues to advance excellence in health sciences through education and innovation.

Awards

Prof. Dr. Silvia María Díaz Prado 🏅 has been honored with seven prestigious research awards 🧪, reflecting the high regard in which her scientific contributions are held by the academic community 🌍. These accolades underscore her exceptional merit, dedication to innovation, and impactful work in the field of biomedical research 🧬. Each award stands as a testament to her relentless pursuit of knowledge, excellence, and advancement in science 🔍✨. Prof. Díaz Prado’s achievements not only bring recognition to her individual efforts but also elevate the institutions and research teams she represents, inspiring future generations of scientists 🎓🌟.

Research Focus

Prof. Dr. Silvia María Díaz-Prado is a distinguished researcher in the field of Regenerative Medicine 🧬🦴, with a strong focus on stem cells, cartilage repair, and molecular signaling in musculoskeletal disorders. Her groundbreaking work explores microRNA profiling🧪, mesenchymal stem cells🧫, and the human amniotic membrane as a novel source for cell therapy. She also investigates oncogenic pathways like Wnt, Notch, and Hedgehog 🔬, linking them to cancer stem cells. Prof. Díaz-Prado’s contributions bridge molecular biology with clinical applications, making her a key figure in orthopedic tissue engineering, biomarkers, and cell-based therapeutic strategies.

Publication Top Notes

Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes

Cloning genes from a library using a clustering strategy and PCR

Multilineage differentiation potential of cells isolated from the human amniotic membrane

Human amniotic membrane as an alternative source of stem cells for regenerative medicine

Wnt signalling and cancer stem cells

Notch signalling in cancer stem cells

Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair

Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

Isolation and characterization of mesenchymal stem cells from human amniotic membrane

Induced pluripotent stem cells for cartilage repair: current status and future perspectives

Biology of BMP signalling and cancer

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Published on by Top Pharmaceutical

nisreen kaddim | Drug Delivery Systems | Best Innovation Award

Dr. nisreen kaddim, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nisreen Kaddim Radi is an Assistant Professor at the University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🧬. Her research focuses on antimicrobial resistance, food safety, and innovative antibacterial films for medical applications 🏥. She has presented at international conferences and published extensively in high-impact journals 📚. Passionate about advancing science, she integrates computational and experimental approaches to explore anticancer and antibacterial agents ⚗️. With a commitment to research and education, Dr. Nisreen inspires students and contributes to scientific innovation 🌍.

Publication Profile

Google Scholar

Professional Background

Dr. Nisreen Kaddim Radi 🎓 is an Assistant Professor at the College of Science for Women, University of Babylon, specializing in molecular biology, genetics, PCR, and virology 🦠, with a focus on food safety and packaging 🍱. She is a member of the Arab Association for Science and Technology, Iraq branch, and serves on the Educational Guidance Committee at her college. Dr. Nisreen has published numerous research papers and actively participates in global conferences 🌍, including the 2022 International Conference on Sustainable Development Goals in Istanbul, ICAB 2022 at the University of Basrah, and ICAB2 2024, where she presented her studies on antimicrobial resistance, genetic variation, and immunological research

Memberships

Dr. Nisreen Kaddim Radi 🔬 is a dedicated researcher with significant contributions to molecular biology, genetics, and virology 🧬. Although she does not hold editorial positions or industry collaborations, her active engagement in scientific research strengthens her impact in the field. As a member of the Arab Association for Science and Technology 🌍, she remains connected to a network of experts, enhancing her academic and professional credibility. Through her research and participation in international conferences, Dr. Nisreen continues to contribute valuable insights to the scientific community, particularly in food safety and antimicrobial resistance 🦠.

Innovation in Methodology

Dr. Nisreen Kaddim Radi 🔬 combines computational simulations with experimental studies to develop innovative methods for enhancing the effectiveness of antibacterial and anticancer agents 🦠🎗️. Her dual-approach methodology integrates cutting-edge technology with practical applications, demonstrating a high level of scientific innovation 🚀. By bridging computational modeling with real-world experimentation, she contributes to advancing medical and pharmaceutical research, aligning perfectly with the award’s objectives 🏆. Her work not only improves therapeutic outcomes but also paves the way for more efficient and targeted treatments, reinforcing her role as a leading researcher in molecular biology and biotechnology 🧬.

Research Excellence

Dr. Nisreen Kaddim Radi 🔬 is pioneering the development of antibacterial films by integrating nanomaterials, polymers, and plant extracts 🌱🦠. Her innovative approach has profound implications for both medical and industrial applications 🏥🏭, positioning her at the forefront of antibacterial and anticancer material research 🎗️. Her groundbreaking study, Integrative Computational and Experimental Study of Propolis, Polyvinyl Alcohol, and Alhagi maurorum Complex as Anticancer and Antibacterial Agents 📜, showcases a multidisciplinary methodology, blending computational modeling with experimental validation 💻⚗️. This research enhances therapeutic potential, contributing to the advancement of novel biomedical materials and precision-targeted treatments 🚀.

Research Focus

Dr. Nisreen Kaddim Radi’s research primarily focuses on medical microbiology 🦠, immunology 🧬, and infectious diseases 🏥. Her work extensively explores viral infections such as Varicella Zoster Virus (VZV) 🏵️, Human Papillomavirus (HPV) 🎗️, and Hepatitis B Virus (HBV) 🦠, investigating genetic susceptibility and immune response. She also examines bacterial resistance 🧫, particularly in foodborne pathogens like E. coli, and studies immunological markers 🧪 in various infections. Her contributions in genetic polymorphisms 🔬, cytokine responses 🌡️, and molecular typing of pathogens highlight her expertise in understanding disease mechanisms and improving diagnostic approaches in infectious diseases and immunological disorders.

Publication Top Notes

Investigation of oxidative stress in patient with Varicella Zoster Virus (VZV) infection

Human genetic variation susceptibility associated with HBV: analysis of genetic markers susceptibility to hepatitis b among patients in babylon province

Genetic study of TORCH infections in women with bad obstetric history: multiplex polymerase chain reaction for detection of common pathogens and agents of congenital infections

Evaluation of CD4 and CD8 in Patients Infected with Genital Wart Caused by Human Papilloma Virus in Babylon Province/Iraq

Evaluation of serum IgE, TNF alpha at patients with genital warts, Iraq.

Immunological Study for Patient with Verruca Vulgaris and Verruca Plana Caused by HPV in Hilla/Iraq

The effect of manganese poisoning on the histological structure of testis in male Swiss mice

Bacteriological Study of Tonsillitis Patients and Estimation of Concentrations of Certain Immunological Parameters.

The distribution of antimicrobial resistance and the presence of virulence genes in Escherichia coli isolated from frozen chicken meat in Iraq

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Published on by Top Pharmaceutical

Nibras Mohammed Sahi | Drug Delivery Systems | Women Researcher Award

Assist. Prof. Dr. Nibras Mohammed Sahi, Ministry of Higher Education and Scientific Research, University of Babylon, Iraq

Dr. Nebras Mohammed Sahi 🦋, an Assistant Professor at the University of Babylon, specializes in entomology and plant extracts 🌿. Her research explores insect-derived products and medicinal plant applications in anticancer and antibacterial treatments 🧪. She has contributed to high-impact journals 📄 indexed in SCI and Scopus. Dr. Sahi prepared the propolis and Alhagi maurorum extract used in her latest research. Her work advances medicine, agriculture, and sustainability 🌍. With a citation index of 3, she actively collaborates on innovative biological studies. 💡🔬

Publication Profile

orcid

Professional Background

Dr. Nibras Mohammed Sahi 🦋, an Assistant Professor, specializes in entomology and plant extracts, focusing on the study of insects and their beneficial products. Her research explores the diverse applications of insect-derived compounds in medicine 💊, agriculture 🌱, and sustainability 🌍. Through collaborations with universities and research institutions, she investigates innovative ways to harness the potential of insects for ecological and economic benefits. Driven by a passion for scientific discovery 🔬, Dr. Sahi’s work contributes to advancements in bio-based solutions, aiming to enhance environmental conservation and agricultural productivity while promoting sustainable development.

Ongoing Research

Dr. Nibras Mohammed Sahi 🦋 is actively engaged in research on insect-derived products and plant extracts, with a particular focus on propolis 🐝 and Alhagi maurorum 🌿 for cancer 🧬 and antibacterial 🦠 applications. Her studies explore the therapeutic potential of these natural compounds, aiming to develop innovative solutions in medicine 💊 and biotechnology. While her work aligns with prestigious award categories, highlighting specific project funding 💰, collaborations 🤝, or research grants would further strengthen her academic profile. Through her dedication to scientific discovery 🔬, Dr. Sahi contributes to advancements in natural product research and sustainable healthcare solutions.

Professional Memberships

Dr. Nibras Mohammed Sahi 🦋 has not listed any editorial appointments, active collaborations, or professional memberships. However, participation in scientific societies 🏛️, international conferences 🎤, or editorial boards 📑 would significantly enhance her academic profile. Engaging in peer-reviewed journals 📚, contributing to scientific committees 🏅, or collaborating on global research initiatives 🌍 would further establish her influence in the field of entomology and natural product research. Highlighting such professional engagements would strengthen her candidacy, showcasing her dedication to advancing scientific knowledge 🔬 and fostering collaborations that drive innovation in medicine 💊, agriculture 🌱, and sustainability 🌿.

Research Focus

Assist. Prof. Dr. Nibras Mohammed Sahi’s research primarily focuses on microbiology 🦠, antibiotic resistance 💊, and bioactive compounds 🌱. His studies encompass pathogenic bacteria identification 🧫, antimicrobial activity testing 🧪, and molecular genetics 🧬 related to infectious diseases. He has extensively investigated natural plant extracts 🌿 and fungal metabolites 🍄 for their antibacterial and antifungal properties, along with genetic factors in diseases 🧑‍⚕️ like hepatitis B and colorectal cancer. His work also extends to insecticidal bioactive compounds 🪲 and their effects. His research contributes significantly to public health 🏥, pharmacology 💉, and molecular diagnostics 🔬.

Publication Top Notes

Molecular & Antibiotic Sensitivity Pattern Study of Acute Otitis Media, Tonsillitis & Periodontitis among Different Ages of Patients of Al-Hashmia General Hospital, Primary Care Centers & Private Clinic in Babylon Province

Analysis of Methanolic extract of Secondary Metabolites Released by Candida glabratus using GC-MS and Evaluation of Its Antimicrobial Activity

Detection of Bioactive Compounds of Raphanus sativus Using GC-MS and FT-IR Technical Analysis and Determination of its Anti-Bacterial and Anti-Fungal Activity.

Isolation and Identification of Some Pathogenic Bacteria from Otitis Media in Babylon Governorate

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

Antimicrobial Effect of the Crude Phenolic, Alkaloid and Terpenoid Compounds Extracts of Myrtus Communis L. against Human Gram-Negative Pathogenic Bacteria

HamidReza Ahmadifar | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

HamidReza Ahmadifar | Drug Delivery Systems | Best Researcher Award

Assist. Prof. Dr. HamidReza Ahmadifar, University of Guilan, Iran

Dr. HamidReza Ahmadifar is an Assistant Professor in the Computer Engineering Department at the University of Guilan, Iran. He earned his Ph.D. in Computer Engineering from Shahid Beheshti University in 2013. His research focuses on Cloud Computing ☁️, Blockchain Applications 🔗, Computer Architecture 🖥️, and Approximate Computing ⚡. He has contributed to multiple research projects, published in reputable journals, and serves as a reviewer for IEEE and other high-impact publications. His innovative work includes a blockchain-based model for counterfeit detection in logistics. Passionate about technological advancements, he continues to shape the future of computing. 🚀

Publication Profile

Google scholar

Professional Background

Assist. Prof. Dr. HamidReza Ahmadifar 🎓 earned his Ph.D. in Computer Engineering from Shahid Beheshti University, Tehran, Iran, in 2013. Currently, he serves as an Assistant Professor in the Computer Engineering Department at the University of Guilan, Rasht, Iran 🏛️. His research focuses on Computer Architecture 🖥️, Approximate Computing 🤖, Cloud Computing ☁️, and Blockchain Applications 🔗. With a strong academic background and expertise in emerging technologies, Dr. Ahmadifar actively contributes to advancing computational methodologies and innovative digital solutions, shaping the future of computing and technology. 🚀

Professional Memberships

Assist. Prof. Dr. HamidReza Ahmadifar 🎓 is an active member of the academic and research community, contributing as a reviewer for prestigious journals. He serves as a reviewer for the IEEE Open Journal of Intelligent Transportation Systems 🚗💡, where he evaluates cutting-edge research on smart mobility and transportation technologies. Additionally, he reviews for Computers in Biology and Medicine 🧬💻, assessing innovative studies at the intersection of computing and healthcare. His commitment to peer review ensures the quality and advancement of scientific research, reinforcing his influence in both computing and interdisciplinary applications. 🔍📚

Technical Contributions

Assist. Prof. Dr. HamidReza Ahmadifar 🎓 has made significant contributions to technological innovation, particularly in counterfeiting detection. His groundbreaking research utilizes blockchain technology 🔗 and GPS systems 📍 to enhance product authentication without relying on additional IoT sensors. This innovative approach ensures both cost-effectiveness 💰 and high security 🔒, making implementation more accessible across industries. By eliminating extra hardware requirements, Dr. Ahmadifar’s model streamlines authentication processes while maintaining reliability and authenticity. His work represents a major advancement in digital security, reinforcing trust in supply chains and counterfeit prevention solutions. 🚀

Collaborations

Assist. Prof. Dr. HamidReza Ahmadifar 🎓 actively collaborates with industry and academia, contributing to four consultancy and industry projects 🏭🔍 that bridge research with real-world applications. His ability to translate theoretical knowledge into practical solutions ⚙️ highlights his impact in the field. Additionally, his involvement in collaborative research papers 📄🤝 showcases his commitment to knowledge sharing and teamwork. Through these partnerships, Dr. Ahmadifar plays a key role in advancing cutting-edge technologies 🚀 while fostering innovation across multiple domains. His contributions strengthen the connection between academic research and industry-driven technological advancements. 🔗

Research Focus

Assist. Prof. Dr. HamidReza Ahmadifar’s research primarily focuses on computer architecture 🖥️, digital systems ⚙️, artificial intelligence 🤖, and blockchain applications 🔗. His work includes innovations in Residue Number Systems (RNS) ➗, hardware-efficient computing 🏗️, and digital arithmetic optimization 📊. He has contributed to modular arithmetic, reconfigurable computing 🛠️, and image processing 🖼️. Additionally, his studies extend to deep learning-based systems 🧠, cloud computing ☁️, and cybersecurity 🔐. His interdisciplinary research integrates signal processing 📡, transport security 🚛, and smart cities 🌆, impacting various technological domains.

Publication Top Notes

A New Residue Number System with 5-Moduli Set: {22q, 2q±3, 2q±1}

Estimation of (vapour + liquid) equilibrium of binary systems (tert-butanol + 2-ethyl-1-hexanol) and (n-butanol + 2-ethyl-1-hexanol) using an artificial neural

A ROM‐less reverse RNS converter for moduli set {2q ± 1, 2q ± 3}

Improved modulo-(2n ± 3) multipliers

Reducing reconfiguration time of reconfigurable computing systems in integrated temporal partitioning and physical design framework

Application of image processing techniques for quality control of mushroom

Dmap: A distributed blockchain-based framework for online mapping in smart city

Performance of HEVC discrete cosine and sine transforms on GPU using CUDA

Adder-Only Reverse Converters for 5-Moduli Set {2^q,2^q-1,2^(q+1)±1,2^(q+2)-1}

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

 

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Published on by Top Pharmaceutical

YORINOBU MAEDA | Drug Delivery Systems | Pharmaceutical Advancement Award

Prof Dr YORINOBU MAEDA, Fukuyama university, Japan

Prof. Dr. Yorinobu Maeda, Ph.D. (Hiroshima University, 1990), is a renowned expert in drug safety, pharmacokinetics, and infection control. As a professor at Fukuyama University and Drug Safety Director, he has advanced renal function-based dosing and prescription optimization. His contributions have earned him multiple awards, including Best Paper Awards (2001, 2005) and an Academic Contribution Award (2014) from the Japanese Society of Pharmaceutical Health Care and Sciences. With a strong academic and clinical impact, Dr. Maeda is a leading figure in pharmaceutical advancements, ensuring better patient safety and treatment efficacy. 🏅🔬

Publication Profile

scopus

Educational and Professional Background

Prof. Dr. Yorinobu Maeda has a distinguished background in pharmaceutical sciences, earning his Ph.D. from Hiroshima University in 1990 🎓. His expertise spans infection control, hospital pharmacy specialization, and drug safety leadership, reflecting his dedication to pharmaceutical advancements 💊. With leadership roles in major hospitals 🏥 and an esteemed position as a professor at Fukuyama University 🎓, he has made significant academic and practical contributions to the field. His work continues to shape the future of pharmacy, ensuring patient safety and advancing healthcare practices for better medical outcomes 🌍🔬.

Contributions to Pharmaceutical Sciences

Prof. Dr. Yorinobu Maeda has made significant contributions to pharmaceutical sciences, particularly in drug safety, pharmacokinetics, and dosage optimization 💊🔬. His research focuses on infection control 🦠, renal function-based dosing 🏥, and improving prescription practices, directly enhancing patient safety and treatment efficacy 👨‍⚕️✅. As a Drug Safety Director, he plays a crucial role in advancing pharmaceutical practices, ensuring medications are used effectively and safely. His dedication to optimizing drug therapy and refining medical protocols continues to have a lasting impact on healthcare, improving outcomes for patients worldwide 🌍💉.

Awards and Recognitions

Prof. Dr. Yorinobu Maeda has made remarkable contributions to the field of pharmaceutical healthcare, earning numerous prestigious accolades from the Japanese Society of Pharmaceutical Health Care and Sciences. His achievements include the Best Paper Awards in 2001 and 2005 🏆, as well as the esteemed Academic Contribution Award in 2014 🎓. These honors highlight his dedication to advancing research and implementing pharmacokinetic principles to enhance patient safety and care 🩺. Dr. Maeda’s work stands as a testament to his unwavering commitment to improving healthcare standards and fostering innovation in pharmaceutical sciences. 🌟

Research Focus

Professor Dr. Yorinobu Maeda is an eminent researcher specializing in pharmaceutical sciences, with a primary focus on drug bioavailability, prodrug development, and therapeutic drug monitoring. His work spans areas such as drug absorption, small intestinal bacterial overgrowth diagnosis, and managing adverse drug reactions. Notable research includes the impact of metal ions on drug efficacy and innovative prodrug strategies. Through collaborative studies, he contributes to optimizing drug delivery systems and clinical pharmacotherapy, enhancing patient safety and treatment outcomes. 🧪💊

Publication Top Notes

5-Aminosalicylic Acid Distribution into the Intestinal Membrane Along the Gastrointestinal Tract After Oral Administration in Rats

Development and Evaluation of EDTA-Treated Rabbits for Bioavailability Study of Chelating Drugs Using Levofloxacin, Ciprofloxacin, Hemiacetal Ester Prodrugs, and Tetracycline

Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion

Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells

Effect of aluminium ion on bioavailability of levofloxacin following oral administration of cilexetil ester of levofloxacin as prodrug in rats

 Study on the infusion-site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant

Dosage adjustment of dabigatran etexilate based on creatinine clearance in patients with cardioembolic stroke or atrial fibrillation

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

 

Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Assist. Prof. Dr. Liqun Jiang | Drug Delivery Systems | Best Researcher Award

Xuzhou Medical University, China

Author Profile

🎓Early Academic Pursuits 

Liqun Jiang began his academic journey with a deep interest in pharmaceutical sciences and biotechnology. His foundational studies were driven by a passion for discovering innovative solutions to pressing medical challenges. During his early years, Jiang demonstrated exceptional aptitude in the fields of drug development and delivery systems, excelling in both theoretical and applied sciences. These formative experiences laid the groundwork for his future endeavors in advanced pharmaceutical research. Jiang’s dedication to academic excellence led him to pursue specialized training and advanced education, equipping him with the knowledge and skills essential for groundbreaking contributions to medical science.

🌟Professional Endeavors 

Currently serving as an Associate Professor at Xuzhou Medical University, Liqun Jiang has established himself as a key figure in pharmaceutical engineering. His role extends beyond teaching, as he actively participates in high-impact research initiatives. A youth member of the Pharmaceutical Engineering Committee of the Chinese Pharmaceutical Society, Jiang is deeply involved in projects focused on novel drug delivery systems, particularly for respiratory diseases.

He has been instrumental in nearly 10 prestigious research projects, including the national 863 Program and major drug innovation programs. Jiang has successfully overseen the development of approximately 10 products, ranging from pharmaceuticals and disinfection solutions to specialized medical foods. His collaborative efforts with pharmaceutical companies have led to the development of a drug liposome inhalation agent, which has now progressed to pilot production stages.

🔬Contributions and Research Focus 

Jiang Liqun’s research is primarily centered on novel drug delivery systems for respiratory diseases, with a particular emphasis on pulmonary edema. His contributions to the field are both diverse and impactful, including: Developing pressure-sensitive multivesicular liposomes for delivering amlodipine besylate, Innovating therapies with exogenous eNOS genes to combat high-altitude pulmonary edema, Utilizing mesenchymal stem cell exosomes for advanced inhalation therapies, Designing high-efficiency powder mist inhalants for high-altitude conditions.

🏆Accolades and Recognition 

Liqun Jiang’s academic and professional achievements have garnered widespread recognition. His research contributions are evidenced by: Nearly 30 peer-reviewed publications in reputed journals, 10 authorized patents, with 8 more under processing, An impressive citation index of 312, reflecting the high impact of his work, Close collaborations with pharmaceutical companies, leading to tangible advancements in drug development and commercialization, Jiang’s dedication to his field is further highlighted by his active participation in the Chinese Pharmaceutical Society, where he contributes as a youth member in shaping the future of pharmaceutical engineering.

🌏Impact and Influence 

Jiang Liqun’s work has had a profound impact on both academia and industry. His innovative strategies for addressing respiratory diseases have paved the way for safer, more effective therapeutic interventions. By integrating cutting-edge drug delivery systems into clinical practice, Jiang has set a benchmark in the treatment of pulmonary conditions. His ability to bridge the gap between research and application has made him a valuable collaborator for pharmaceutical companies seeking to bring advanced therapies to market.

🌟Legacy and Future Contributions 

Jiang Liqun’s legacy lies in his relentless pursuit of innovation and excellence in pharmaceutical research. His groundbreaking work in drug delivery systems has already influenced the development of treatments for high-altitude pulmonary edema and other respiratory conditions. Looking ahead, Jiang aims to expand his research into broader areas of pulmonary medicine, focusing on the use of biotechnology and nanotechnology in drug development. He envisions a future where precision medicine and targeted therapies play a pivotal role in treating respiratory diseases, improving outcomes for patients worldwide. Jiang is committed to mentoring the next generation of researchers and fostering collaborations that advance the frontiers of pharmaceutical science.

🌟Final Thoughts 

With a career marked by innovation, dedication, and impactful contributions, Liqun Jiang exemplifies the qualities of a trailblazing researcher. His work continues to shape the future of respiratory medicine, leaving an indelible mark on both academia and industry. Through his ongoing efforts, Jiang inspires a new wave of scientific inquiry and collaboration, ensuring his legacy will resonate for years to come.

📖Notable Publications

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema
  • Authors : Li, H., Liu, S., Dai, W., … Jin, F., Jiang, L.
  • Journal: Controlled Release
  • Year: 2024
Inhalation of panaxadiol alleviates lung inflammation via inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells
  • Authors : Wang, Y., Wei, H., Song, Z., … Shu, Q., Xie, Y.
  • Journal: Ginseng Research
  • Year: 2024
Dry Powder Formulations for Inhalation Require a Smaller Aerodynamic Diameter for Usage at High Altitude
A large particle size is required by a nano/micron sized-fluticasone propionate inhalable suspension for asthma treatment
A simple liposome-based bionic bacterium for tumor treatment by re-education of tumor-associated microphages in combination with chemotherapy

Prof. Lei Ren |Drug Delivery Systems| Best Researcher Award-1331

Published on by Top Pharmaceutical

Prof. Lei Ren|Drug Delivery Systems |Best Researcher Award|

Prof. Lei Ren at mus alparslan university, Turkeys

PROFILE  

Orcid 

Early Academic Pursuits 📚

Lei Ren’s academic journey began in the vibrant city of Tianjin, where she pursued her Bachelor of Science in Material Science & Engineering at Tianjin University, graduating in 1990. This foundational period was marked by her strong dedication to understanding the principles of material science, a field that would later shape her illustrious career. Tianjin University’s rigorous curriculum provided Ren with a solid grounding in the fundamentals of material science, equipping her with the skills and knowledge to explore its applications in various domains.

Ren’s academic curiosity led her to pursue further education at Peking Union Medical College, one of China’s most prestigious institutions. In 1997, she earned her Master of Science in Biomedical Engineering, a field that bridged her interests in material science and its applications in medicine. This interdisciplinary approach was a hallmark of Ren’s early academic endeavors, reflecting her passion for integrating diverse fields of study to address complex scientific challenges.

Her pursuit of knowledge did not stop there. Ren continued her academic journey in Japan, where she completed her Ph.D. in Material Science at Okayama University in 2001. This period was crucial in shaping her research trajectory, as she delved into advanced materials and their potential biomedical applications. Her time in Japan also exposed her to a new scientific culture, broadening her perspective and fostering a global approach to research that would later define her career.

Professional Endeavors 🌟

Upon completing her doctoral studies, Ren embarked on a career that seamlessly blended research and academia. Her first professional role was as a Research Associate at the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, where she worked from 1990 to 1997. During this time, Ren honed her research skills, contributing to various projects that explored the interface between material science and biomedical engineering.

In 2001, Ren transitioned to a global stage, joining the Singapore-MIT Alliance at the National University of Singapore as a Research Fellow. This opportunity allowed her to collaborate with leading scientists from around the world, further enhancing her research capabilities and expanding her professional network. Her work during this period focused on cutting-edge biomedical engineering projects, laying the groundwork for her future contributions to the field.

In 2002, Ren returned to China to join the Research Center of Biomedical Engineering at the College of Medicine, Xiamen University, as an Associate Professor. Over the next five years, she played a pivotal role in advancing the center’s research agenda, mentoring students, and publishing influential papers. Her dedication and expertise earned her a promotion to full Professor in 2007, a position she holds to this day at the Department of Biomaterials, College of Materials, Xiamen University.

Contributions and Research Focus 🧬

Ren’s research has primarily focused on the development and application of biomaterials, particularly in the context of biomedical engineering. Her work has explored the synthesis and characterization of novel materials designed to interact with biological systems, with the goal of improving medical devices, implants, and tissue engineering applications.

One of her significant contributions to the field has been her research on biocompatible materials that can be used in medical implants. Ren’s work has helped advance the understanding of how materials interact with the human body, leading to the development of safer and more effective implants that reduce the risk of rejection and improve patient outcomes. Her research has also explored the use of biomaterials in tissue engineering, where she has contributed to the development of scaffolds that support the growth and regeneration of tissues.

In addition to her work on biomaterials, Ren has also been involved in interdisciplinary projects that integrate material science with other fields, such as nanotechnology and regenerative medicine. Her ability to bridge these diverse areas of study has positioned her as a leader in the field of biomedical engineering, with her work having a profound impact on both academic research and practical medical applications.

Accolades and Recognition 🏅

Throughout her career, Lei Ren has received numerous accolades in recognition of her contributions to the field of biomedical engineering. Her research has been widely published in leading scientific journals, earning her a reputation as a highly respected scholar in her field. Her work has also been recognized by various professional organizations, both in China and internationally, highlighting her status as a pioneering figure in the field of biomaterials.

Ren has been invited to speak at numerous international conferences, where she has shared her insights on the latest developments in biomaterials and biomedical engineering. These speaking engagements have not only showcased her research but also facilitated the exchange of ideas with other leading scientists, furthering the advancement of the field.

Impact and Influence 🌍

Ren’s influence extends beyond her research and academic roles. As a professor at Xiamen University, she has mentored numerous students who have gone on to make their own contributions to the field of biomedical engineering. Her commitment to teaching and mentorship has helped shape the next generation of scientists, ensuring that her impact will be felt for years to come.

Moreover, Ren’s work has had a tangible impact on the medical field. The biomaterials she has developed have been used in various medical devices and implants, improving the quality of life for patients around the world. Her interdisciplinary approach to research has also inspired new collaborations between scientists from different fields, leading to innovative solutions to some of the most pressing challenges in medicine.

Legacy and Future Contributions 🔮

As Lei Ren continues her work at Xiamen University, her legacy as a pioneer in the field of biomaterials is already well established. Her contributions to the development of biocompatible materials and her interdisciplinary approach to research have left an indelible mark on the field of biomedical engineering. Moving forward, Ren is likely to continue pushing the boundaries of what is possible in her field, exploring new frontiers in material science and its applications in medicine.

🎓Publication 

Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy

  • Authors   :Chufan Wang; Haobo Tang; yufei Duan; Qiang Zhang; Wenjun Shan; Xiumin Wang; Lei Ren
  • Journal    :Colloid and Interface Science
  • Year         :2024

Tumor‐Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano‐Vaccine for Overcoming Immune Barriers for Effective and Long‐Term Cancer Immunotherapy

  • Authors   :Chufan Wang; Jinglian Zhao; Yufei Duan; Liping Lin; Qiang Zhang; Haiping Zheng; Wenjun Shan; Xiumin Wang; Lei Ren
  • Journal    :Healthcare Materials
  • Year         :2024

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays

  • Authors   :Lihuang Li; Jialing Zhang; Zhengqi Jiao; Xi Zhou; Lei Ren; Miao Wang.
  • Journal    :Materials
  • Year         :2024

Generalized Multifunctional Coating Strategies Based on Polyphenol-Amine-Inspired Chemistry and Layer-by-Layer Deposition for Blood Contact Catheters

  • Authors   :Jiahao Du; Xiaoting Zhang; Wenlong Li; Miao Wang; Xi Zhou; Lei Ren
  • Journal    :Biomaterials Science & Engineering
  • Year         :2024

Driving modes and characteristics of biomedical micro-robots

  • Authors   :Engineered Regeneration
    .

  • Journal    :Libing Huang; Yueyuan Pan; Miao Wang; Lei Ren
  • Year         :2023

Prof Dr. Mohamed Attia shafie|Formulation Science| Innovator in Pharmaceutical Research Award

Published on by Top Pharmaceutical

Prof Dr. Mohamed Attia shafie,Formulation Science,Innovator in Pharmaceutical Research Award

Prof Dr. Mohamed Attia shafie, at Faculty of Pharmacy,Egypt

PROFILE

Orcid
Scopus

 

🎓Early Academic Pursuits :

Professor Mohamed Attia Shafie began his academic journey at Assiut University, Egypt, where he pursued his Bachelor’s degree in Pharmacy and Pharmaceutical Chemistry, graduating in 1969. His interest in the field propelled him to further his education at the same institution, where he obtained a Master’s degree in Pharmaceutics in 1972. His research focused on the interactions between plastic containers and certain liquid pharmaceutical preparations, highlighting his early engagement with the critical aspects of pharmaceutical formulation.

In pursuit of deeper knowledge and expertise, Professor Attia Shafie moved to the First Medical Institute in Moscow, USSR, to complete his Ph.D. in 1978. His doctoral research on the formulation of ophthalmic preparations included extensive studies on the physico-chemical properties and pharmacokinetics of an ophthalmic ointment containing sulfapyridine and hydrocortisone acetate. This foundation set the stage for his future contributions to the field of pharmaceutics.

🏫Professional Endeavors :

Professor Attia Shafie’s professional career spans several decades, primarily focused on teaching and research in the field of pharmaceutics. He has held numerous esteemed positions at various academic institutions. Currently, he is a Professor of Pharmaceutics at the Faculty of Pharmacy, Assiut University, where he has been teaching since 2011. He is responsible for imparting knowledge on topical preparations to students and has made significant contributions to curriculum development.

Before his current role, he served as the Head of the Pharmaceutical Technology Department at the German University in Cairo from 2006 to 2011, where he taught quality assurance and current good manufacturing practices (cGMP). His leadership extended to Assiut University, where he was the Professor and Head of the Pharmaceutics Department from 2002 to 2006, teaching courses in biopharmaceutics and dosage form design.

In addition to his academic roles, Professor Attia has garnered experience in the pharmaceutical industry. He worked as a consultant for Liptis Pharmaceuticals and Cid Pharmaceutical Company, where he contributed to product development and quality control from 2004 to 2006. He also served as a Production Manager at T3A Pharmaceutical Company from 1999 to 2000, managing the production of various pharmaceutical dosage forms.

🔬Contributions and Research Focus :

Throughout his career, Professor Attia Shafie has made substantial contributions to pharmaceutical sciences, particularly in the areas of ophthalmic preparations, buccal delivery, and the oral delivery of proteins and peptides. His research has led to the development of innovative formulations, including prednisolone-loaded cationic nanoemulsions for uveitis management, and Sertaconazole-PLGA nanoparticles for managing ocular keratitis.

His publication record is extensive, with numerous articles in reputable journals such as the Journal of Drug Delivery Science and Technology and Pharmaceutics. His work on chitosan nanoparticles for ocular delivery and the formulation of topical delivery systems for fungal infections highlights his commitment to advancing drug delivery technologies.

🏆Accolades and Recognition :

Professor Attia Shafie’s contributions to the field have been widely recognized. His research has not only advanced the understanding of drug delivery systems but has also significantly influenced clinical practices in ophthalmology. His published works are frequently cited, reflecting his impact on both academia and the pharmaceutical industry. His ability to bridge the gap between theoretical research and practical application has earned him a reputation as a leading expert in pharmaceutics.

🌍Impact and Influence :

Professor Attia Shafie’s impact extends beyond research and teaching; he has influenced a generation of pharmacy students and professionals. His emphasis on quality assurance and formulation design has shaped the curricula of various pharmacy programs. By mentoring students and guiding them through their academic journeys, he has fostered a new generation of pharmacists and researchers who are well-equipped to tackle future challenges in the pharmaceutical field.

His work has also contributed to the development of safer and more effective pharmaceutical products, thereby enhancing patient care and outcomes. Through collaborations with pharmaceutical companies, he has facilitated the translation of research findings into practical solutions that address real-world health issues.

 

🎓Publication 

Sertaconazole-PLGA nanoparticles for management of ocular keratitis

Prednisolone loaded-cationic nanoemulsion formulation for uveitis management

Permeation-Enhancing Nanoparticle Formulation to Enable Oral Absorption of Enoxaparin

High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes

 

Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells